Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...

Morgan Stanley (MS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Morgan Stanley (NYSE:MS – Get Free Report) is set to issue its quarterly earnings data before the market opens on Thursday, ...

Morgan Stanley (MS) stock saw a decline, ending the day at $126.88 which represents a decrease of $-1.76 or -1.37% from the prior close of $128.64. The stock opened at $129.65 and touched a low of ...

Investors with a lot of money to spend have taken a bearish stance on Morgan Stanley MS. And retail traders should know. We ...

Morgan Stanley closed $8.38 short of its 52-week high ($136.24), which the company achieved on November 25th.

BofA raised the firm’s price target on Morgan Stanley (MS) to $146 from $140 and keeps a Buy rating on the shares. Strong Q3 results ...

Morgan Stanley expects improving freight conditions and upcoming emissions regulations to boost global truck manufacturers in ...

Shares of Morgan Stanley MS shed 1.37% to $126.88 Tuesday, on what proved to be an all-around dismal trading session for the ...

Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from ...